Search research articles
Contact Us
Filters
Showing results (551-560 of 594) with videos related to
Page
of 60
Sort By:
Nature Communications
|
December 7, 2021
The histologic phenotype of lung cancers is associated with transcriptomic features rather than genomic characteristics
Ming Tang, Hussein A Abbas, Marcelo V Negrao, et al.
Cancer Immunology, Immunotherapy : CII
|
April 18, 2020
<sup>18</sup>F-fluorodeoxyglucose positron emission tomography correlates with tumor immunometabolic phenotypes in resected lung cancer
Kyle G Mitchell, Behrang Amini, Yunfei Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 21, 2020
A Phase I/II Study of Neoadjuvant Cisplatin, Docetaxel, and Nintedanib for Resectable Non-Small Cell Lung Cancer
Tina Cascone, Boris Sepesi, Heather Y Lin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 3, 2016
The BATTLE-2 Study: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer
Vassiliki Papadimitrakopoulou, J Jack Lee, Ignacio I Wistuba, et al.
Nature Communications
|
January 30, 2021
Evolution of DNA methylome from precancerous lesions to invasive lung adenocarcinomas
Xin Hu, Marcos R Estecio, Runzhe Chen, et al.
Cancer Discovery
|
April 18, 2025
Depletion of effector regulatory T cells associates with major response to induction dual immune checkpoint blockade
Xianli Jiang, Nils-Petter Rudqvist, Bo Jiang, et al.
Nature Communications
|
August 20, 2021
Nodal immune flare mimics nodal disease progression following neoadjuvant immune checkpoint inhibitors in non-small cell lung cancer
Tina Cascone, Annikka Weissferdt, Myrna C B Godoy, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
February 14, 2023
Analysis of Immune Intratumor Heterogeneity Highlights Immunoregulatory and Coinhibitory Lymphocytes as Hallmarks of Recurrence in Stage I Non-Small Cell Lung Cancer
Alejandro Francisco-Cruz, Pedro Rocha, Alexandre Reuben, et al.
Journal for Immunotherapy of Cancer
|
June 30, 2025
Phase II basket trial of Dual Anti-CTLA-4 and anti-PD-1 blockade in Rare Tumors (DART) SWOG S1609: pancreatic neuroendocrine neoplasm (PNEN) cohort
Sandip Pravin Patel, Jillian Fisher, Young Kwang Chae, et al.
Gut
|
July 10, 2020
Naproxen chemoprevention promotes immune activation in Lynch syndrome colorectal mucosa
Laura Reyes-Uribe, Wenhui Wu, Ozkan Gelincik, et al.
Page
of 60
Search research articles
Search
Showing results (551-560 of 594) with videos related to
Sort By:
Page
of 60
Nature Communications
|
December 7, 2021
The histologic phenotype of lung cancers is associated with transcriptomic features rather than genomic characteristics
Ming Tang, Hussein A Abbas, Marcelo V Negrao, et al.
Cancer Immunology, Immunotherapy : CII
|
April 18, 2020
<sup>18</sup>F-fluorodeoxyglucose positron emission tomography correlates with tumor immunometabolic phenotypes in resected lung cancer
Kyle G Mitchell, Behrang Amini, Yunfei Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 21, 2020
A Phase I/II Study of Neoadjuvant Cisplatin, Docetaxel, and Nintedanib for Resectable Non-Small Cell Lung Cancer
Tina Cascone, Boris Sepesi, Heather Y Lin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 3, 2016
The BATTLE-2 Study: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer
Vassiliki Papadimitrakopoulou, J Jack Lee, Ignacio I Wistuba, et al.
Nature Communications
|
January 30, 2021
Evolution of DNA methylome from precancerous lesions to invasive lung adenocarcinomas
Xin Hu, Marcos R Estecio, Runzhe Chen, et al.
Cancer Discovery
|
April 18, 2025
Depletion of effector regulatory T cells associates with major response to induction dual immune checkpoint blockade
Xianli Jiang, Nils-Petter Rudqvist, Bo Jiang, et al.
Nature Communications
|
August 20, 2021
Nodal immune flare mimics nodal disease progression following neoadjuvant immune checkpoint inhibitors in non-small cell lung cancer
Tina Cascone, Annikka Weissferdt, Myrna C B Godoy, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
February 14, 2023
Analysis of Immune Intratumor Heterogeneity Highlights Immunoregulatory and Coinhibitory Lymphocytes as Hallmarks of Recurrence in Stage I Non-Small Cell Lung Cancer
Alejandro Francisco-Cruz, Pedro Rocha, Alexandre Reuben, et al.
Journal for Immunotherapy of Cancer
|
June 30, 2025
Phase II basket trial of Dual Anti-CTLA-4 and anti-PD-1 blockade in Rare Tumors (DART) SWOG S1609: pancreatic neuroendocrine neoplasm (PNEN) cohort
Sandip Pravin Patel, Jillian Fisher, Young Kwang Chae, et al.
Gut
|
July 10, 2020
Naproxen chemoprevention promotes immune activation in Lynch syndrome colorectal mucosa
Laura Reyes-Uribe, Wenhui Wu, Ozkan Gelincik, et al.
Page
of 60